SVF Pauling (Cayman) Ltd insider trades: Relay Therapeutics (RLAY) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where SVF Pauling (Cayman) Ltd reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 25, 2026 | RLAY | ↓ Sell | 6,000,000 | $19.40 | $116.4M | Indirect | Aug 28, 2026 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other RLAY insiders
Open-market trades in the last 12 months
About SVF Pauling (Cayman) Ltd's insider trades
SVF Pauling (Cayman) Ltd is a 10% owner of Relay Therapeutics (RLAY). Since Aug 25, 2026, it has reported no open-market purchases and 1 sale worth $116.4M on SEC Form 4. In the last 12 months: 1 sale ($116.4M).
Its filings also include conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RLAY insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.